Blockbuster Pathology Deal Sees Japan’s Miraca Holdings Pay $725 Million to Acquire Caris Diagnostics

Oct 12, 2011 | Laboratory News, Uncategorized

Deal may be just the first of more clinical laboratory acquisitions in the U.S by Japan’s largest medical lab testing company Pathology and clinical laboratory testing companies continue to go global and last week’s big acquisition in anatomic pathology gave one of Japan’s biggest clinical laboratory companies an important foothold in the United States. Miraca Holdings Inc. (TYO: 4544.T) of Tokyo, Japan, announced that it would acquire the anatomic pathology business of Caris Life Sciences,...

Novartis To Pay $470 million To Buy Pathology Testing Company Genoptix

Jan 25, 2011 | Laboratory News, Laboratory Pathology

Cancer Testing and Molecular Diagnostics Are Main Drivers in This Transaction In a deal with implications for independent clinical pathology laboratories, pharmaceutical giant Novartis (NYSE: NVS) announced that it would acquire pathology testing company Genoptix, Inc. (NASDAQ: GXDX). Novartis will pay $470 million in cash to acquire all the shares of Genoptix. Although the total amount of $470 million to be paid for Genoptix is nearly one-half billion dollars, one financial analyst who...
;